Skip to main content

Table 3 Results of transbronchial lung biopsy, bronchial lavage and BAL

From: Diagnostic yield, safety, and impact of transbronchial lung biopsy in mechanically ventilated, critically ill patients: a retrospective study

Specimen n (%)
Transbronchial lung biopsy 42
Organizing pneumonia 23 (54.8)
Diffuse alveolar damage 4 (9.5)
Drug-induced lung toxicity 4 (9.5)
Purulent bronchopneumonia 2 (4.8)
Acute exacerbation of ILD 1 (2.4)
Granulomatous disease (Tb) 1 (2.4)
Non-small cell lung cancer 1 (2.4)
Silicosis 1 (2.4)
Bronchial lavage 41
Cytomegalovirus (PCR) 3
Pseudomonas aeruginosa (culture) 3
Herpes simplex virus (PCR) 1
Aspergillus fumigatus (culture) 1
Klebsiella oxytoca (culture) 1
Stenotrophomonas maltophilia (culture) 1
Enterococcus faecalis (culture) 1
Pneumocystis jiroveci (PCR) 1
Mycobacterium tuberculosis (culture) 1
Broncho-alveolar lavage (BAL) 21
Neutrophilia 13 (61.9%)
Neutrophilia, Eosinophilia 3 (14.3%)
Neutrophilia, Eosinophilia, Lymphocytosis 2 (9.5%)
Neutrophilia, Lymphocytosis 1 (4.8%)
Lymphocytosis 1 (4.8%)
Normal cell distribution 1 (4.8%)
  1. Normal cell distribution of BAL refers to ≥85% of alveolar macrophages, ≤ 15% lymphocytes, ≤ 3% neutrophils, and ≤ 1% eosinophils
  2. Abbreviations: OP organizing pneumonia, ILD interstitial lung disease, Tb tuberculosis, PCR polymerase chain reaction